Walgreens will pay up to $350M in settlement with DOJ to resolve opioid prescription lawsuit
Walgreens will pay up to $350M in settlement with DOJ to resolve opioid prescription lawsuit
Fierce Healthcare; by Heather Landi; 4/21/25
Walgreens has agreed to pay $300 million to settle allegations from federal prosecutors that it illegally filled millions of invalid prescriptions for opioids and other controlled substances, the Department of Justice (DOJ) announced Monday. The DOJ also alleges that the retail pharmacy chain sought payment for many of those "invalid" prescriptions by Medicare and other federal healthcare programs in violation of the False Claims Act. The settlement amount is based on Walgreens’s ability to pay, the DOJ said, but Walgreens will owe the U.S. an additional $50 million if the company is sold, merged or transferred prior to fiscal year 2032.